The European Medicines Agency said Friday it has been asked by the European Commission to conduct a review of certain arthritis drugs following the worldwide withdrawal of Merck &amp; Co.'s Vioxx medication.
Less than a week after Merck &amp; Co. yanked its popular Vioxx arthritis drug off the market, the New England Journal of Medicine voiced strong concerns Wednesday about the safety of Pfizer's bestselling Celebrex.
